Skip to main content
VCbacked
Log inGet Started

Toregem BioPharma

Kawaramachi, Japan

Toregem BioPharma is a startup from Kyoto University that develops a treatment and tooth regeneration drug for congential adential.

$2.6M raised
Apr 2026
Venture - Series Unknown
BiotechnologyHealth CareMedicalPharmaceutical

Top Investors

Kyoto University Innovation CapitalMiraidoaKyogin Lease & CapitalGemsekiAstellas Venture Management

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Toregem BioPharma

How much funding has Toregem BioPharma raised?
Toregem BioPharma has raised $2.6M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Who are Toregem BioPharma's investors?
Toregem BioPharma's investors include Kyoto University Innovation Capital, Miraidoa, Kyogin Lease & Capital, Gemseki, Astellas Venture Management.
Where is Toregem BioPharma headquartered?
Toregem BioPharma is headquartered in Kawaramachi, Japan.
What does Toregem BioPharma do?
Toregem BioPharma is a startup from Kyoto University that develops a treatment and tooth regeneration drug for congential adential.
What stage is Toregem BioPharma at?
Toregem BioPharma is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Toregem BioPharma — Funding & Investors." VCBacked, April 27, 2026, https://www.vcbacked.co/company/toregem-biopharma. Accessed June 3, 2026.
APA
VCBacked. (2026). Toregem BioPharma — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/toregem-biopharma
Wikipedia (cite web)
{{cite web |title=Toregem BioPharma — Funding & Investors |url=https://www.vcbacked.co/company/toregem-biopharma |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong